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Arsenic is an established lung, skin, and blad-
der carcinogen [International Agency for
Research on Cancer (IARC) 2004]; however,
the carcinogenic mechanisms are currently
under investigation. Based primarily on stud-
ies of highly exposed populations in Taiwan
and elsewhere, the U.S. Environmental
Protection Agency (EPA) recently reduced the
maximum contaminant level (MCL) standard
for arsenic in drinking water from 50 μg/L to
10 μg/L (U.S. EPA 2006). At the lower end of
the dose–response curve, the biologic effects
and magnitude of disease risk in the human
population remain unknown (Abernathy et al.
1999). However, a growing number of labora-
tory studies, both in cell cultures and in experi-
mental animals, have demonstrated biologic
effects of As at very low levels equivalent to
those below the new 10 μg/L standard. These
effects include endocrine disruption, altered
cell signaling, altered cell cycle kinetics, altera-
tions in proliferative response, and other effects
that may be associated with carcinogenesis and
other disease processes (reviewed by Rossman
2003). Thus, it is important to understand the
potential adverse effects of such exposure in
the human population.
An estimated 2% of the drinking water
serving U.S. households contains ≥ 2 μg/L As
(National Research Council 2001). Approxi-
mately 40% of households in the state of New
Hampshire are served by unregulated private
wells, with homeowner-financed, optional
contaminant testing. Moreover, until recent
studies revealed the extent of geologic As cont-
amination of drinking water in the state
(Peters et al. 1999), As was not part of the
standard laboratory water testing panel. Case–
control studies of bladder and skin cancer con-
ducted in the New Hampshire population
have detected evidence of elevated cancer risks.
For bladder cancer, an excess risk was observed
primarily among smokers exposed to As in the
drinking water, supporting hypotheses that
these levels of As are cocarcinogenic (Karagas
et al. 2001, 2004). Likewise, drinking water in
the southwestern United States and northern
Mexico contains As at concentrations above
the new MCL of 10 μg/L (Meza et al. 2004).
The precise mechanism of As cocarcino-
genesis is unknown. It has been difficult to
detect genotoxic effects of As per se at environ-
mental levels [Agency for Toxic Substances
and Disease Registry (ATSDR) 1999; IARC
2004; Rossman 2003]. However, many stud-
ies support the role of As in altering one or
more DNA repair processes [World Health
Organization (WHO) 2001]. Arsenic has been
shown to potentiate the genotoxicity of other
organic mutagen-carcinogens, particularly poly-
cyclic aromatic hydrocarbons (PAHs), includ-
ing benzo[a]pyrene (BAP) and ultraviolet
radiation (UVR) (ATSDR 1999; Rossman
2003). Rats treated with As and BAP sus-
tained adduct burdens longer than did rats
treated with BAP alone, suggesting impair-
ment of DNA repair by As as a possible
mechanism (Tran et al. 2002). A study using
human fibroblasts found that low (2.5 μM,
~ 180 μg/L) concentrations of arsenite
reduced nucleotide excision repair efficiency,
and incision frequency in particular, after
UVR exposure (Hartwig et al. 1997). Results
of another study in cultured human fibro-
blasts indicated that As exposure reduced
DNA repair capacity as measured by the
comet assay (Curnow et al. 2001). The effects
of As are strongly dose, time, and species
dependent (Barchowsky et al. 1999; WHO
2001). In particular, several As-induced
effects exhibit a biphasic characteristic. For
example, low (≤ 1–2 μM) doses of As in cell
culture increase cell proliferation and enhance
endocrine signaling, whereas higher but still
noncytotoxic doses (2–5 μM) suppress these
same pathways (Barchowsky et al. 1999).
Likewise, patterns of altered gene expression,
as detected by DNA microarray studies,
demonstrated very different patterns at low
versus higher doses (Andrew et al. 2003b).
Thus, although animal and cell culture stud-
ies provide controlled model systems for
mechanistic studies of As, it is critical to
understand which of these findings translate
into cellular, molecular, and clinical effects in
actual human exposure situations, and the
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The mechanism(s) by which arsenic exposure contributes to human cancer risk is unknown; how-
ever, several indirect cocarcinogenesis mechanisms have been proposed. Many studies support the
role of As in altering one or more DNA repair processes. In the present study we used individual-
level exposure data and biologic samples to investigate the effects of As exposure on nucleotide
excision repair in two study populations, focusing on the excision repair cross-complement 1
(ERCC1) component. We measured drinking water, urinary, or toenail As levels and obtained
cryopreserved lymphocytes of a subset of individuals enrolled in epidemiologic studies in New
Hampshire (USA) and Sonora (Mexico). Additionally, in corroborative laboratory studies, we
examined the effects of As on DNA repair in a cultured human cell model. Arsenic exposure was
associated with decreased expression of ERCC1 in isolated lymphocytes at the mRNA and protein
levels. In addition, lymphocytes from As-exposed individuals showed higher levels of DNA damage,
as measured by a comet assay, both at baseline and after a 2-acetoxyacetylaminofluorene (2-AAAF)
challenge. In support of the in vivo data, As exposure decreased ERCC1 mRNA expression and
enhanced levels of DNA damage after a 2-AAAF challenge in cell culture. These data provide fur-
ther evidence to support the ability of As to inhibit the DNA repair machinery, which is likely to
enhance the genotoxicity and mutagenicity of other directly genotoxic compounds, as part of a
cocarcinogenic mechanism of action. Key words: arsenic, arsenite, DNA repair, ERCC1, molecular
epidemiology, nucleotide excision repair. Environ Health Perspect 114:1193–1198 (2006).
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role of these in pathophysiologic processes
such as carcinogenesis. In our preliminary
study of human lymphocytes from individuals
exposed to drinking water As, As exposure
was correlated in a strongly dose-dependent
manner to decreased expression of three
nucleotide excision repair genes: ERCC1,
XPB, and XPF (Andrew et al. 2003a).
The objective of this investigation was to
evaluate our preliminary observation of an
association between As exposure, focusing on
ERCC1 gene expression levels in a larger num-
ber of individuals with exposure data and bio-
logic samples. In addition to gene expression,
we investigated the effects of As exposure at
both the protein and DNA repair functional
levels. We then extended our investigation
into another population exposed to similar
levels of As in Mexico and also performed
in vitro As experiments to validate our results
in a controlled system.
Materials and Methods
Human populations. New Hampshire. We
selected subjects from an ongoing epidemio-
logic study of bladder cancer in New
Hampshire (Karagas et al. 1998, 2004).
Selection was based on high or low As expo-
sure from individuals on whom we had col-
lected cryopreserved lymphocytes. Within
this subset (n = 37), the drinking water As
levels of the low-exposure group averaged
0.7 μg/L (range, 0.007–5.3 μg/L), whereas
the high-exposure group averaged 32 μg/L
(range, 10.4–74.7 μg/L). Data on subject’s
exposure history were available through a per-
sonal interview covering demographic infor-
mation, history of tobacco use, and other
lifestyle factors. Informed consent was
obtained from each participant, and all proce-
dures and study materials were approved by
the Committee for the Protection of Human
Subjects at Dartmouth College.
Subjects agreed to provide a venous blood
sample that was drawn into cell prep tubes
(CPT) containing citrate and a lymphocyte
isolation gradient. Blood tubes were main-
tained at 4°C and sent to the study laboratory
for processing and analysis. No later than
24 hr after the blood draw, the lymphocytes
collected in CPTs containing sodium citrate
were isolated according to the manufacturer’s
instructions using standard buoyant density
centrifugation methods. After centrifugation,
first plasma was removed, aliquoted, and
frozen at –80°C, and then the mononuclear
cells were removed by pipette and cryo-
preserved (–120°C) using freezing media at a
controlled rate of 1°C/min. This procedure
has previously been demonstrated to ensure
approximately 90% viability after thawing
(Wei et al. 1994).
Additionally, toenail clipping samples col-
lected at the time of interview were analyzed
for As and other trace elements by instrumen-
tal neutron activation analysis (INAA) at the
University of Missouri research reactor using
a standard comparison approach as described
previously (Cheng et al. 1995). The detection
limit for As measured by INAA is approxi-
mately 0.001 μg/g. A water sample from the
current household drawn into commercially
washed (mineral-free) high-density poly-
ethylene bottles (Fisher Scientific, Suwanee,
GA, USA) that meet U.S. EPA standards for
water collection (U.S. EPA 2002) were ana-
lyzed for As concentration using an Agilent
7500c Octopole inductively coupled plasma
mass spectrometer (Agilent Technologies Inc.,
Palo Alto, CA, USA) in the Dartmouth Trace
Element Analysis Core Facility (Karagas et al.
2000).
Sonora, Mexico. Subjects were recruited
in 2004 from several towns in the Yaqui
Valley of Sonora, Mexico, by contact through
local health care officials after attending an
informational meeting in their hometowns, as
described previously (Meza et al. 2004). The
present study involved a subset of subjects
who provided biologic samples (n = 16). They
ranged in age from 23 to 63 years and were in
good health (self-reported and by physical
examination). All subjects gave their informed
consent, as approved by the Human Subjects
Committee of the University of Arizona and
the Ministry of Public Health of Sonora
State. Physical data and data on the health
status, cigarette smoking, dietary habits, and
other variables were collected by question-
naire and physical examination. Individuals
from the town of Esperanza were exposed to
drinking water As levels from two wells meas-
ured multiple times, with a combined mean
of 43.3 ± 8.4 μg As/L. A comparable group of
individuals from another town, Colonia
Allende, were exposed to lower levels of As
from one well of 5.5 ± 0.20 μg As/L. This
well water was the sole source of drinking
water for these subjects. Blood collection and
processing were performed using similar
methods to those described above for New
Hampshire subjects.
First-morning-void urine samples were
obtained in 100 mL polypropylene bottles and
kept on ice. Within 6 hr, cooled samples were
taken to the Institute Technologic of Sonora
and kept frozen at –40°C. The accumulated
samples were then shipped on dry ice to the
University of Arizona, where the samples were
stored at –80°C until the analysis of total As,
and As species was performed as described pre-
viously (Meza et al. 2005). The detection limits
were 0.42–1.08 μg/L for As compounds.
Cell line. We used Jurkat lymphoblast cells
as a controlled in vitro system to evaluate the
effects of As on DNA damage and repair. Cells
were grown in suspension in RPMI medium
containing L-glutamine with 10% fetal
bovine serum (Atlanta Biologicals, Norcross,
GA, USA) and 1% penicillin-streptomycin
(Mediatech Inc., Herndon, VA, USA). Cells
were exposed to 0.01–10 μM sodium arsenite
(Sigma, St. Louis, MO, USA), which is
equivalent to 0.75–750 μg/L, for a period of
24 hr before harvesting and RNA isolation
for gene expression analysis. Cells were
exposed in culture to 0 or 1 μM (equivalent
to 75 μg/L) As as sodium arsenite for 24 hr
before the comet assay was performed, as
described below.
Gene expression analysis. RNA was har-
vested using Trizol reagent (Gibco/BRL Life
Technologies, Gaithersburg, MD, USA) fol-
lowed by DNase digestion using DNAfree
(Ambion Inc., Austin, TX, USA) according
to the manufacturer’s instructions and quanti-
tated by spectrophotometric absorbance at
260 nm. We performed real-time reverse-
transcription polymerase chain reaction
(RT-PCR) using gene-specific primers and
reagents (Applied Biosystems, Foster City,
CA, USA) and the ABI PRISM sequence
detection system and software (Applied
Biosystems). Briefly, total RNA (0.5 μg) was
reverse transcribed using 100 U M-MLV
(Maloney murine leukemia virus) reverse
transcriptase in a mixture with oligo-dT and
dNTPs (deoxyribonucleotide triphosphates)
according to the instructions provided with
the Qiagen Omniscript kit (Qiagen, Valencia,
CA, USA). Samples were reverse transcribed
in a PTC-100 thermocycler (MJ Research
Inc., Watertown, MA, USA) for 60 min at
44°C, and the reaction was terminated by
heating to 95°C for 10 min. Expression of
ERCC1 [excision repair cross-complementing
rodent repair deficiency, complementation
group 1; GenBank gene ID 2067 (GenBank
2006)] was assessed by real-time PCR using
10 ng total RNA, 400 nM primers, 200 nM
probe, and TaqMan Universal PCR Master
Mix (Applied Biosystems). The sequence for
the ERCC1 primer probe set is as follows:
forward, CAGGACTTCGTCTCCCGGT;
probe, TCTGGAACAGCTCATCGCCGCA;
reverse, GCATAAGGCCAGATCTTCT-
CTTG. Relative quantitation was performed
using a standard curve consisting of serial
dilutions of pooled sample cDNA from the
same source as the test RNA with each plate.
Relative expression levels of each gene
were normalized to 18s rRNA or GAPDH
(Applied Biosystems).
Protein levels. We assessed the level of
ERCC1 protein by immunoblotting using
sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE) to resolve pro-
teins from whole-cell lysates. Lymphocytes
were rinsed with ice-cold stop buffer
(10 mM Tris-HCl, pH 7.4, 10 mM EDTA,
5 mM EGTA, 100 mM NaF, 200 mM
sucrose, 100 μM Na-orthovanadate, 5 mM
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pyrophosphate, 4 μg/mL leupeptin, 4 μg/mL
soybean trypsin inhibitor, 1 mM benzami-
dine, 20 μM calpain inhibitor 1, 100 mU/mL
aprotinin, and 100 μM phenylmethyl-
sulfonylfluoride). The stop buffer was then
replaced with a minimal volume of 2× SDS-
PAGE buffer (62.5 mM Tris-HCl, pH 6.8,
10% glycerol, 2% SDS, 5% β-mercap-
toethanol, 0.05% wt/vol bromophenol blue).
The lysates were boiled for 5 min and clari-
fied by centrifugation at 13,000 rpm for
10 min. Equal amounts of cell lysate were
resolved by electrophoresis on 8–12% SDS-
polyacrylamide gels. Electrophoresis was per-
formed at constant voltage (200 V), and then
the resolved proteins were transferred from
the polyacrylamide gel to polyvinylidene
difluoride membrane (PVDF; Immobilon-P;
Millipore, Bedford, MA, USA) by semidry
transfer (Hoeffer Semiphor, San Francisco,
CA, USA) for 1 hr at constant current
(32 mA/minigel) using transfer buffer
(25 mM Tris, 192 mM glycine, 20% vol/vol
methanol, 0.01% SDS). To eliminate non-
specific interactions of antibodies with the
membrane, the PVDF membrane was blocked
with TTBS (10 mM Tris-HCl, pH 8.0,
150 mM NaCl, 0.05% Tween-20) containing
5% milk (wt/vol) for 1 hr at room tempera-
ture or overnight at 4°C. The membrane was
incubated with the primary ERCC1 antibody
(Neomarkers; Lab Vision Co., Fremont, CA,
USA) diluted 1:200 in TTBS overnight at
4°C. The membrane was washed three times
with TTBS and incubated with horseradish
peroxidase–linked sheep anti-mouse IgG
(1:2,000 in TTBS) (Amersham Pharmacia
Biotech, Piscataway, NJ, USA) for 0.5–1 hr at
room temperature. After three washes with
TTBS, protein bands were visualized by
enhanced chemiluminescence using the
Renaissance system (NEN Life Sciences,
Boston, MA, USA) and film (Lumi-Film;
Roche Molecular Biochemicals, Indianapolis,
IN, USA).
DNA damage and repair assessment. The
single-cell gel electrophoresis or comet assay is
widely used to measure DNA damage and
repair in primary human lymphocytes by
measuring strand breaks and apurinic sites
(Baltaci et al. 2002; De Silva et al. 2000;
Rajaee-Behbahani et al. 2001; Schmezer et al.
2001). We divided the lymphocyte sample
from each individual into parts to assess dam-
age at several time points. We assessed base-
line DNA damage levels as well as the capacity
of the lymphocytes to repair damage induced
by an in vitro challenge with 2-acetoxyacetyl-
aminofluorene (2-AAAF; Midwest Research
Institute, Kansas City, MO, USA), the reac-
tive and genotoxic metabolite of 2-acetyl-
aminofluorene. Alkaline-labile 2-AAAF
adducts are primarily repaired through the
nucleotide excision repair pathway (van Steeg
2001). Aliquots of lymphocytes were chal-
lenged for 2 hr in vitro with 4 μM 2-AAAF. A
subset of 2-AAAF–challenged lymphocytes
were incubated for an additional 4 hr to allow
for DNA repair of the lesions. Comet analysis
was performed using materials and protocols
from Trevigen Inc. (Gaithersburg, MD,
USA). Briefly, cells were mixed with agarose
and spread over a warmed, precoated micro-
scope slide. The agarose was allowed to solid-
ify for 30 min at 4°C, followed by immersion
in prechilled lysis solution for 45 min or
overnight. Next, the slides were placed in
freshly prepared alkaline solution, pH > 13,
for 30 min at room temperature. The slides
were then washed twice by immersion in
1× Tris-Borate-EDTA buffer for 5 min.
Electrophoresis was carried out in alkaline
buffer for 20 min at 1 V/cm (measured elec-
trode to electrode) in the dark. Last, the slides
were dipped into 70% ethanol for 5 min,
allowed to dry completely, and stained with
SYBR green (Trevigen). Image analysis of
each cell was performed to quantify the length
of the comet and the intensity of staining. All
cells were analyzed using a fluorescence micro-
scope coupled to the MD Biotech comet assay
image analysis system (Morgantown, WV,
USA). The Olive tail moment is a unitless
measure of DNA damage that was calculated
as described previously (Olive et al. 1990)
using the quantity of migrated DNA multi-
plied by the distance between the comet head
and the center of gravity of the DNA in the
comet tail. The quantity of migrated DNA is
the fraction of the DNA that has migrated
from the head. The quantity of DNA is
assessed as the DNA staining intensity sub-
tracted from the background intensity. We
scored the tail moment of all cells in a given
well. Each point represents an average of
50 lymphocytes per individual (for human
studies) or culture (for in vitro studies) from at
least three to nine individuals or six cultures.
Statistical analysis. We performed statisti-
cal analysis for gene expression and immuno-
blotting using analysis of variance with
Newman-Keuls posttest, unpaired t-test, or lin-
ear regression procedures in GraphPad PRISM
software (GraphPad Software Inc., San Diego,
CA, USA). We considered p-values < 0.05 to
be statistically significant. Statistical computa-
tions and graphics for comet analysis were per-
formed using the S-Plus statistical package
(version 6.2; Insightful Corporation, Seattle,
WA, USA). We plotted the mean Olive tail
moment with 95% confidence interval (CI) for
each treatment group as a function of time.
We performed an unpaired two-sided t-test to
compare the low- and high-As groups at each
time point. Linear regression was used to assess
the slopes of the lines. Corresponding p-values
are indicated.
Results
Demographic characteristics of the study
populations are shown in Table 1. A larger per-
centage of the subjects in Mexico were female.
In addition, the Mexican population tended to
be younger, with a mean age of 37 years, com-
pared to a mean age of 64 years in New
Hampshire subjects. Approximately one-third
of each population consisted of smokers.
As shown in Figure 1, analysis of both As-
exposed populations combined indicated that
individuals exposed to drinking water As con-
centrations ≥ 6 μg/L (n = 11) had lower
ERCC1 gene expression levels than those with
< 6 μg/L As (n = 42; p < 0.05). The Mexican
population alone had a lower ERCC1 level
among individuals exposed to As ≥ 6 μg/L,
although this was not statistically significant.
Likewise, a lower ERCC1 level was observed
in the New Hampshire individuals exposed to
≥ 6 μg/L As (statistically significant at
p < 0.05).
We further assessed As exposure using
available internal biomarkers of As level.
However, different biomarkers were used in
the two populations, which prevented pooling.
Arsenic decreases DNA repair
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Table 1. Percentage of the New Hampshire and
Mexican populations with the selected characteris-
tics.
New Hampshire Mexico Combined
(n = 37) (n = 16) (n = 53)
Sex 
Male 73 44 64
Female 27 56 36
Age (years)
≤ 50 8 81 30
> 50 92 19 70
Current smoking
Yes 32 38 34
No 68 62 66
Water As (µg/L)
≤ 6 89 56 79
> 6 11 44 21
*
*
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Figure 1. ERCC1 gene expression (mean ± SE) by
drinking water As level for individuals from the New
Hampshire (NH) and Mexican populations and for
both populations combined (n = 53). ERCC1 levels
were assessed by RT-PCR and normalized to 18s or
GAPDH as described in “Materials and Methods.” 
*Statistically significant compared to the ≤ 5 µg/L group
(p < 0.05).
Measurements included toenail As for the New
Hampshire population and urinary As for the
Mexican population. These markers correlate
with drinking water As concentration (Karagas
et al. 2000). Linear regression analysis of the
New Hampshire population indicated an
inverse association between toenail As levels
and ERCC1 expression (r2 = 0.4; p < 0.05).
ERCC1 expression decreased with increasing
inorganic urinary As level [As(III) + As(V)] but
not total urinary As (which may include
organic As), although this was not statistically
significant (r2 = 0.08; p = 0.3). In the New
Hampshire population, we found no difference
in ERCC1 expression level according to cancer
status (p = 0.8). For both populations, ERCC1
expression did not significantly differ by smok-
ing status, age, or sex (data not shown).
We went on to investigate whether the
decreased gene expression levels that we
observed in lymphocytes of subjects exposed
to As in New Hampshire translated to changes
in protein levels. Immunoblots using an
ERCC1 antibody indicated lower levels of
ERCC1 protein among individuals exposed to
drinking water As levels > 5 μg/L (p < 0.05),
although there was some interindividual
variation in expression (representative blot
shown in Figure 2A, quantification shown in
Figure 2B).
Additionally, we hypothesized that As
exposure would be associated with correspond-
ingly higher DNA damage levels and reduced
DNA repair function. We analyzed human
lymphocytes from a subset of New Hampshire
residents exposed to low (< 0.7 μg/L) or high
(≥ 13–93 μg/L) levels of drinking water As
using the comet assay (Figure 3). We detected
higher levels of DNA damage, as indicated by
larger Olive tail moments, for lymphocytes
analyzed at baseline from individuals exposed
to high levels of drinking water As in vivo
compared with those from lower level expo-
sures (time 0 hr; p < 0.05). Analysis of these
cells at 2 hr after 2-AAAF challenge demon-
strated a dramatic increase in DNA damage
but did not reveal any statistically significant
differences in the amount of damage at 2 hr by
As exposure status (p = 0.25). However, at the
6-hr time point, after the 4-hr repair period,
significantly higher levels of DNA damage
remained in lymphocytes from individuals
exposed to high compared with low levels of As
in vivo (p < 0.05) (Figure 4). Control lympho-
cytes that did not receive in vitro challenge
showed similar levels of DNA damage at the
6-hr time point (Figure 4). The difference in
slopes of the low- and high-As lines was not
statistically significant.
To further confirm the hypothesis that As
exposure inhibits ERCC1 expression, we
repeated these experimental treatments using
a human lymphoblast cell line. As shown in
Figure 5, As suppressed ERCC1 expression in
the treated cells in a dose-responsive manner,
beginning at the 0.1 μM (~ 7 μg/L) dose,
with statistically significant decreases at
≥ 1 μM (p < 0.05) compared with unexposed
controls.
We further investigated the hypothesis
that As exposure in vitro would decrease
DNA repair function using the lymphoblast
cell line. Arsenic-exposed and -unexposed
cells had similar levels of baseline DNA dam-
age at time 0 hr (Figure 6). Arsenic-exposed
cells challenged with 2-AAAF for 2 hr showed
significantly higher levels of DNA damage
than did 2-AAAF–challenged cells that had
not been exposed to As (time = 2 hr; p < 0.05;
Figure 6). DNA damage for both As-exposed
and -unexposed, 2-AAAF–challenged cells
decreased during the 4-hr repair period
(Figure 6). Nevertheless, DNA damage for
As-exposed cells remained significantly higher
than the nonexposed cells at the 6-hr time
point (p < 0.05; Figure 6).
Discussion
Elucidating the mechanism of As carcinogenic-
ity has been challenging, in part due to the
dose, time, and species specificity of its biologic
effects (Barchowsky et al. 1999; WHO 2001).
Our early study (Andrew et al. 2003a) sup-
ported previous in vitro work showing disrup-
tion of DNA repair gene expression by As. In
the present study, we extended our findings to
two different human populations at the gene
expression, protein, and DNA repair func-
tional levels. Thus, our data provide both
human in vivo and in vitro support for the
hypothesis that As inhibits DNA repair
processes (ATSDR 1999; Hartwig 1998) and
that this has the potential to affect subsequent
exposure to other genotoxic and mutagenic
agents.
The effects of As on DNA damage and
repair have been evaluated almost exclusively in
experimental systems. Previous in vitro studies
demonstrated that As specifically interferes
with the repair of DNA photolesions (Yang
et al. 1992) and cross-linking agents (Yager
and Wiencke 1993). In another study using
human fibroblasts, Hartwig et al. (1997) found
that low (2.5 μM) concentrations of arsenite
reduced nucleotide excision repair efficiency,
and incision frequency in particular, after UVR
exposure. Results of additional studies in cul-
tured human fibroblasts indicated that As
exposure reduced DNA repair capacity and
specifically inhibited the repair of UV-induced
pyrimidine dimer-related DNA damage in
lymphoblastoid cells as measured by the comet
assay (Curnow et al. 2001; Danaee et al. 2004;
Yager and Wiencke 1993).
Differences in gene expression results
between these in vitro studies may be explained
by differences in As dose because the effects of
Andrew et al.
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Figure 2. Association of drinking water As exposure
> 5 µg/L with decreased ERCC1 protein levels in
human lymphocytes from the New Hampshire
population. (A) Immunoblot of protein extracts from
human lymphocytes obtained from a subset of eight
individuals assessed using antibody to ERCC1 or
β-actin. (B) The ratio of band densities of ERCC1 to
β-actin from the immunoblot shown in (A) graphed
by drinking water As concentration; values shown
are mean ± SD. 
*Statistically significant compared to the control group (p
< 0.05).
Low As
High As
Baseline 4 hrIn vitro challenge
Figure 3. Comet assay on human lymphocytes obtained from New Hampshire subjects exposed in vivo to
low or high drinking water As levels. Cells were analyzed at baseline, after in vitro challenge with 2-AAAF,
and after a 4-hr repair period.
As are highly dose dependent. In the present
study, treatment of lymphocytes with > 1 μM
sodium arsenite in vitro decreased ERCC1 gene
expression. The circulating levels of As
achieved in mice after intraperitoneally
administering 0.625 nM As/kg body weight
are approximately equivalent to the 5 μM
in vitro dose and do not cause overt signs of
toxicity (Soucy et al. 2003). In contrast,
acutely toxic doses of As induced stress-
response-pathway genes as well as ERCC1
gene expression in the livers of mice injected
with 100–300 μM As/kg body weight (Liu
et al. 2001). Low concentrations of As induce
cell proliferation, angiogenesis, hormone sig-
naling, and nuclear factor κB–dependent
transcription and do not appear to activate
mitogen-activated protein kinase (MAPK)
signaling or other stress response pathways. In
contrast, high doses of As induce apoptosis
and activate MAPKs, extracellular signal-
regulated kinase (ERK), and p-38, as well as
stress-mimetic and heat-shock–mimetic
responses, inhibition of proliferation, and
apoptosis (Barchowsky et al. 1999). Although
decreased expression of ERCC1 may be partly
responsible for the decreased DNA repair
function associated with As exposure, we
recognize that other pathway members may
be involved, and future investigation will be
needed to elucidate all factors involved.
Because other environmental and genetic fac-
tors can influence DNA repair, we would not
expect complete concordance between As
exposure and expression or function on an
individual level. Nevertheless, our in vitro
studies demonstrate the effects of As within a
controlled experimental system. Further work
is needed to identify genotypes that modify
the influence of As exposure on DNA repair.
In a human population, we previously
found that drinking water As exposure at levels
between 5 and 75 μg/L was associated with
decreased mRNA expression of nucleotide
excision repair pathway genes in lymphocytes
from exposed individuals (Andrew et al.
2003a). Based on those preliminary results,
we then followed up with the present study,
which uses a larger human population in
New Hampshire. In addition to enlarging
the sample size, examination of a second
population in Mexico exposed to moderate
levels of As, supported our New Hampshire
population results. Although we observed
decreased ERCC1 expression in both popula-
tions, the difference was not statistically sig-
nificant in the Mexican population. The
New Hampshire study had more extreme
levels of exposure (Mexico, 5.5–43 μg/L;
New Hampshire, 0.007–75 μg/L), but more
likely the Mexico study had a smaller sample
size and lacked statistical power. To our
knowledge, no other studies have evaluated
the association between As exposure and DNA
repair gene expression or protein levels in
human populations, particularly at As levels
that are in the range that is routinely found in
the United States.
In addition, our comet analysis provides
functional DNA repair data in an As-exposed
human population. These data support previ-
ous observations of decreased DNA repair
capacity after As exposure in vitro (Hartwig
1998). Arsenite has been shown to inhibit
DNA repair and act as a cogenotoxin for the
direct-acting alkylating agent methyl methane-
sulfonate, the indirect-acting PAH BaP, and
UV-induced pyrimidine dimers in white
blood cells and fibroblasts (Curnow et al.
2001; Danaee et al. 2004; Hartmann and
Speit 1996; Okui and Fujiwara 1986). As
observed by Danaee et al. (2004) in a previous
study, our in vitro As exposure appeared to
inhibit the fast component of DNA repair
because the difference is observable after chal-
lenge (Figure 6, time = 2 hr). This difference
in DNA migration remained significantly
higher in the As-exposed group after the repair
period (Figure 6, time = 6 hr). Thus, our
study and others consistently report that As
exacerbates DNA damage induced by other
mutagens.
Whether inorganic As can directly induce
DNA damage by itself is more controversial,
and previous studies of DNA damage and
mutagenesis by physiologic levels of inorganic
As have been inconsistent (Mass et al. 2001;
Schwerdtle et al. 2003; Sordo et al. 2001; Yih
and Lee 2000). Our in vitro comet data did
not show an increase in DNA migration after
24 hr treatment with 1 μM As alone (Figure 6,
time = 0 hr), but we did observe higher DNA
damage levels at baseline in cells harvested
from individuals exposed to drinking water As
at levels ≥ 13 μg/L compared to those with low
levels of As (< 1 μg/L). The basis for this
increase remains to be determined; however,
higher levels of DNA damage in these
lymphocytes after 2-AAAF challenge, and the
slower repair kinetics of this damage, suggest
that the higher baseline levels may be a result
of As-inhibited repair and exposure to other
DNA-damaging agents.
In summary, our in vitro studies of As
exposure and our novel work using in vivo As
exposure in two human populations support
the hypothesis that As exposure decreases
DNA repair capacity. Further, our data
demonstrate decreased expression of the
nucleotide excision repair pathway member
ERCC1 and decreased repair after 2-AAAF
challenge. These results support the theory that
As can act through a cocarcinogenic mecha-
nism of action, exacerbating the genotoxicity
and mutagenicity of other compounds.
Arsenic decreases DNA repair
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Figure 6. Effect of in vitro As exposure on DNA
damage and repair function in a cultured Jurkat
lymphoblast cell line. Cultured cells were exposed
in vitro to 0 or 1 µM As for 24 hr (n = 6 independent
cultures). Cells from each culture were analyzed by
single-cell gel electrophoresis immediately after
harvest (time = 0 hr), after a 2-hr in vitro challenge
with 4 µM 2-AAAF (time = 2 hr), and after a 4-hr
repair period (time = 6 hr). See “Materials and
Methods” for details. Values represent mean ± 95%
confidence interval. 
*Statistically significant compared to the control group
(p < 0.05).
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Figure 4. Comet assay results associated with
in vivo As exposure in human lymphocytes from the
New Hampshire population. Cells from 12 individual
subjects were each divided into three subsets and
analyzed immediately after harvest (time = 0 hr;
p < 0.001), after a 2-hr in vitro challenge with 4 µM
2-AAAF (time = 2 hr; p = 0.248), and after a 4-hr
repair period (time = 6 hr; p < 0.001). See “Materials
and Methods” for details.
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Figure 5. Effect of in vitro As exposure on ERCC1
expression in a cultured Jurkat lymphoblast cell
line. Cells were harvested after exposure to As
(0.01–10 µM) for 24 hr. ERCC1 mRNA expression
level was assessed by RT-PCR, quantitated using a
standard curve using known amounts of cDNA, and
normalized to 18s rRNA, as described in “Materials
and Methods.” Values shown are mean ± SD. 
*Statistically significant compared to the control group
(p < 0.05).
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